Finanzielle Vergleiche Vericel Corporation

Aktien

A12FU4

US92346J1088

VCEL

Pharmazeutika

Markt geschlossen - Nasdaq 22:00:00 14.02.2025 % 5 Tage % 1. Jan.
57.09 USD +0.49% Intraday Chart für Vericel Corporation -2.16% +3.97%
Hauptkonkurrenten
Zu einer Liste hinzufügen
Umsatz (Y-1) Nettogewinn (Y-1) EBIT-Marge (Y-1) ROE (Y-1) ROA (Y-1) Verschuldungsgrad (Y-1)
198 Mio. 1.61%3.27% - - -
14.8 Mrd. 17.85%25.76%15.94%7.12%2.22x
2.85 Mrd. 23.21%30.14%9.12%5.26%-0.16x
5.81 Mrd. 6.53%12.51%8.83%5.07%1.61x
9.68 Mrd. 16.87%31.16%10.36%5.95%1.06x
74.43 Mio. 3.49%10.09%2.44%1.34%13.25x
4.24 Mrd. 0.77%9.76%5.27%3.72%-4.29x
464 Mio. 30.08%34.32%22.39%18.84%3.15x
2.42 Mrd. 6.93%6.54%3.51%2.54%0.05x
777 Mio. 22.64%25.43%9.97%7.81%-2.15x
2.2 Mrd. 10.89%20.27%7.98%3.81%2.51x
7.46 Mrd. 15.25%17.71%29.09%18.29%-0.34x
875 Mio. 16.56%27.06%8.84%5.38%10.88x
9.3 Mio. 6’913.92%6’528.75% - 108.65%-2.18x
1.12 Mrd. 22.34%27.94%6.06%5.7% -
271 Mio. 88.41%85.67%159.21% - 0.93x
7.29 Mrd. 0.9%15.52%3.72%1.04%6.42x
731 Mio. 21.42%34.84%11.93%8.19% -
296 Mio. 26.45%32.41%33.98% - -
753 Mio. 27.74%39.28%13.7%9.61%0x
Durchschnitt 3.12 Mrd. -341.71% -317.99% -1.3% -2.95% 2.06x
Gewichteter Durchschnitt nach Marktkapitalisierung 6.08 Mrd. -128.8% -115.44% 5.64% 2.01% 1.73x
Biopharmazeutika